Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish

Neurotoxicology. 2017 Jan:58:103-109. doi: 10.1016/j.neuro.2016.11.006. Epub 2016 Nov 17.

Abstract

The pesticide rotenone is widely used to produce Parkinson's disease (PD)-like symptoms in rodents, but few studies have examined whether rotenone-treated zebrafish can serve as an animal model of PD. Here, we report that 4 weeks of rotenone treatment induced motor and non-motor PD-like symptoms in adult zebrafish. Compared with control fish, rotenone-treated fish spent less time swimming at a fast speed, indicating a deficit in motor function. In the light-dark box test, rotenone-treated fish exhibited longer latencies to enter the dark compartment and spent more time in the light compartment, reflecting anxiety- and depression-like behavior. Furthermore, rotenone-treated fish showed less of an olfactory preference for amino acid, indicating olfactory dysfunction. These behavioral symptoms were associated with decreased levels of dopamine in the brains of rotenone-treated fish. Taken together, these results suggest that rotenone-treated zebrafish are a suitable model of PD.

Keywords: Non-motor symptoms; Parkinson’s disease; Rotenone; Zebrafish.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anxiety / etiology*
  • Dark Adaptation / drug effects
  • Disease Models, Animal
  • Gene Expression Regulation / drug effects
  • Insecticides / toxicity*
  • Locomotion / drug effects
  • Male
  • Neurotransmitter Agents / metabolism
  • Olfaction Disorders / etiology*
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / complications*
  • RNA, Messenger / metabolism
  • Rotenone / toxicity*
  • Zebrafish
  • Zebrafish Proteins / genetics
  • Zebrafish Proteins / metabolism

Substances

  • Insecticides
  • Neurotransmitter Agents
  • RNA, Messenger
  • Zebrafish Proteins
  • Rotenone